ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
42 announcements with these filters
Camlin Fine Sciences reported audited financial results for the year ended March 31, 2026. The board also appointed new executive leadership and internal auditors.
Camlin Fine Sciences reported a fire incident at its Dahej Diphenol Plant, causing ₹2 Crore in losses. Operations remain shut due to raw material supply constraints.
Camlin Fine Sciences scheduled a board meeting for May 26, 2026, to approve audited financial results. Trading window closure from April 1 remains in effect.
Camlin Fine Sciences shareholders approved an increase in authorized share capital via postal ballot with 99.99% majority. The resolution enables future capital raises and MoA amendments.
Camlin Fine Sciences Limited (CFSL) filed a draft simplified cash tender offer with the French AMF to acquire the remaining shares of Vinpai at EUR 3.60 per share. CFSL currently holds 83.82% of Vinpai's share capital and does not intend to implement a squeeze-out procedure.
Camlin Fine Sciences promoter Mr. Ashish Dandekar released a total of 40,96,000 pledged equity shares in two tranches on April 10 and 17, 2026. This follows partial repayment of borrowings to LRSD Securities Private Limited. Post-release, the promoter's total encumbered stake decreased from 9.92% to 7.78%.
Camlin Fine Sciences Ltd promoter Ashish S. Dandekar pledged 37,50,000 shares in total to Aditya Birla Capital and SKS Fincap. The encumbrance involves a ₹10 Crore loan facility to facilitate company borrowing and additional margin requirements. Total promoter encumbered shares now stand at 9.92% of the company's total share capital.
Camlin Fine Sciences Limited received an income tax demand notice of ₹5.47 Crore for Assessment Year 2023-24. The demand arises from Arm’s Length Price adjustments on international and domestic transactions with associated enterprises. The company intends to file an appeal against the order and states there is no immediate impact on operations.
Mr. Ashish Subhash Dandekar, promoter of Camlin Fine Sciences Ltd, pledged 6,50,000 equity shares (0.34% stake) in favor of Ashika Credit Capital Limited on March 30, 2026. This additional margin pledge was created to cover a shortfall in security cover for financial assistance obtained by the company.
Camlin Fine Sciences Limited submitted its quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations for the period ended March 31, 2026. The certificate, issued by MUFG Intime India, confirms that securities received for dematerialisation were processed and listed on the stock exchanges within prescribed timelines.
Camlin Fine Sciences Limited has proposed to increase its authorized share capital from ₹21.50 Crore to ₹25.00 Crore. This move, subject to shareholder approval via postal ballot, provides the company with greater financial flexibility for future growth and capital requirements.
Camlin Fine Sciences is seeking shareholder approval via postal ballot to increase its Authorized Share Capital from ₹21.50 Crore to ₹25.00 Crore. This move is intended to facilitate future fundraising through various equity issuance routes. The e-voting period for this ordinary resolution concludes on May 7, 2026.